News
Less expensive versions of popular weight-loss medications like Wegovy and Zepbound are soon going to be taken off the market ...
Learn how and where to inject Zepbound and where to get additional help. Plus, get tips for injecting the drug at home and ...
Let's look at why this news could be a game-changer for Eli Lilly and its stock.
18h
MedPage Today on MSNMedicaid Often Restricts Access to Heart-Protective Diabetes AgentsMedicaid plans often put up barriers around newer classes of diabetes medications that offer cardioprotection, according to a ...
2h
WISH-TV on MSNApril Indiana Economic UpdateA recent study shows consistent users of Eli Lilly's new weight loss drug, Zepbound, have managed to keep the weight off.
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...
Patients regularly taking Eli Lilly & Co.’s obesity shot Zepbound tend to keep the weight off for at least three years, with ...
Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...
8don MSN
Ryan Rasmussen was determined to lose weight so he would be around to ski and spend time with his wife and children.
The triumph of Ozempic, Wegovy, and related drugs, including Lilly’s Zepbound, has set off a push toward the next frontier: a ...
After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results